Age Related Molecular Degeneration Market

Future Market Insights

Key Insight

The age related molecular degeneration market is projected to grow from USD 12.9 million in 2025 to USD 25.4 million by 2035, at a CAGR of 7.0%. Eylea will dominate with a 42.5% market share, while wet amd will lead the disease type segment with a 65.0% share.

August 04, 2025

Anurag Sharma

300 Pages

Cite this Report

Age Related Molecular Degeneration Market

https://www.futuremarketinsights.com/reports/age-related-macular-degeneration-market

License

Buy Now

Summary ToC Companies

Key Players

Amgen
Bayer
F. Hoffmann-La Roche Ag
Novartis
Ophthotech Corporation
The Vanguard Group

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Age Related Molecular Degeneration Market

Key Players

Similar Industry Reports